Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
37
2024
1248
4.330
 Why?
Early Detection of Cancer
6
2020
162
2.570
 Why?
Ultrasonography, Mammary
8
2020
61
2.190
 Why?
Colorectal Neoplasms
4
2018
236
1.640
 Why?
Mass Screening
3
2020
370
1.580
 Why?
Healthcare Disparities
3
2017
271
1.180
 Why?
Mastectomy
12
2019
143
1.140
 Why?
Mastectomy, Segmental
7
2018
95
1.130
 Why?
Sentinel Lymph Node Biopsy
10
2015
127
1.080
 Why?
Community Health Planning
3
2018
30
1.060
 Why?
Ultrasonography, Interventional
5
2020
146
0.900
 Why?
Biopsy, Large-Core Needle
3
2020
31
0.870
 Why?
Biopsy, Needle
9
2015
195
0.840
 Why?
Neoplasm Staging
13
2020
806
0.820
 Why?
Genetic Counseling
1
2022
43
0.810
 Why?
Health Status Disparities
3
2015
219
0.790
 Why?
Lymph Nodes
7
2015
284
0.790
 Why?
Neoplasms
5
2015
1316
0.780
 Why?
Female
51
2024
28441
0.730
 Why?
Image Interpretation, Computer-Assisted
1
2020
119
0.720
 Why?
Image-Guided Biopsy
2
2020
35
0.700
 Why?
Surgery, Computer-Assisted
2
2018
53
0.690
 Why?
Hematoma
3
2018
60
0.680
 Why?
Middle Aged
37
2021
13088
0.660
 Why?
Polymorphism, Single Nucleotide
2
2018
552
0.650
 Why?
Mandatory Programs
1
2018
25
0.640
 Why?
Adiposity
1
2019
142
0.620
 Why?
Faculty, Medical
3
2021
100
0.610
 Why?
Health Care Costs
1
2018
171
0.600
 Why?
Insurance Coverage
1
2018
107
0.580
 Why?
Humans
56
2024
54284
0.570
 Why?
Disease Management
1
2018
184
0.560
 Why?
Diagnostic Imaging
1
2018
184
0.560
 Why?
Aged
29
2018
10054
0.560
 Why?
Minority Groups
3
2015
136
0.560
 Why?
Arkansas
9
2018
2100
0.530
 Why?
Retrospective Studies
18
2022
6432
0.490
 Why?
Physicians
1
2018
247
0.490
 Why?
Health Planning Councils
1
2014
6
0.490
 Why?
Adult
28
2021
14207
0.480
 Why?
Community-Based Participatory Research
2
2015
209
0.460
 Why?
Health Policy
1
2014
171
0.440
 Why?
Rural Population
1
2017
600
0.430
 Why?
Follow-Up Studies
11
2018
2387
0.420
 Why?
Community Networks
2
2015
54
0.410
 Why?
Community-Institutional Relations
1
2011
51
0.410
 Why?
Aged, 80 and over
13
2018
3431
0.400
 Why?
Carcinoma, Lobular
2
2015
32
0.400
 Why?
Carcinoma, Ductal, Breast
4
2015
96
0.390
 Why?
Population Surveillance
1
2012
183
0.380
 Why?
Physicians, Women
2
2021
24
0.380
 Why?
Neoplasm Recurrence, Local
6
2014
644
0.360
 Why?
Women's Health
1
2010
107
0.350
 Why?
Health Education
2
2008
179
0.340
 Why?
Medical Oncology
1
2010
102
0.340
 Why?
Nipples
5
2013
34
0.310
 Why?
Schools, Medical
2
2020
82
0.310
 Why?
Axilla
6
2015
101
0.310
 Why?
Morbidity
2
2018
149
0.300
 Why?
Socioeconomic Factors
3
2018
642
0.300
 Why?
Health Knowledge, Attitudes, Practice
1
2012
543
0.300
 Why?
Health Services Accessibility
1
2011
432
0.290
 Why?
Physician-Patient Relations
2
2012
150
0.290
 Why?
Breast Diseases
3
2018
24
0.280
 Why?
Mammaplasty
3
2013
45
0.270
 Why?
Catheter Ablation
4
2014
131
0.270
 Why?
Mentors
1
2006
56
0.270
 Why?
Lymphatic Metastasis
7
2015
256
0.260
 Why?
Occult Blood
2
2017
22
0.260
 Why?
Survivors
2
2024
137
0.260
 Why?
United States
7
2022
5217
0.240
 Why?
Magnetic Resonance Imaging
5
2014
1604
0.240
 Why?
Qualitative Research
2
2023
331
0.230
 Why?
Education, Medical, Graduate
2
2022
225
0.220
 Why?
Prognosis
8
2018
2118
0.220
 Why?
Primary Health Care
1
2006
401
0.220
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
34
0.220
 Why?
Empathy
1
2002
50
0.210
 Why?
Problem-Based Learning
1
2002
48
0.210
 Why?
Male
12
2022
27334
0.200
 Why?
Emotions
1
2023
168
0.200
 Why?
Breast
2
2020
92
0.200
 Why?
Democratic Republic of the Congo
1
2020
4
0.200
 Why?
Feasibility Studies
2
2020
398
0.200
 Why?
Atrial Fibrillation
1
2024
197
0.200
 Why?
Genetic Testing
1
2022
135
0.190
 Why?
Dermatologic Surgical Procedures
3
2013
38
0.190
 Why?
Counseling
1
2022
149
0.190
 Why?
Combined Modality Therapy
4
2018
692
0.190
 Why?
Biopsy, Fine-Needle
1
2020
116
0.190
 Why?
Research Support as Topic
1
2020
51
0.180
 Why?
Students, Medical
1
2002
173
0.180
 Why?
Referral and Consultation
1
2022
307
0.180
 Why?
General Surgery
1
2021
113
0.180
 Why?
Surgical Flaps
2
2019
135
0.170
 Why?
Obesity
1
2008
1202
0.170
 Why?
Incidence
2
2024
1082
0.170
 Why?
Patient Satisfaction
2
2019
304
0.170
 Why?
Radiopharmaceuticals
4
2008
238
0.150
 Why?
Adipose Tissue
1
2019
207
0.150
 Why?
Lymphatic Vessels
2
2008
47
0.150
 Why?
Logistic Models
2
2018
995
0.150
 Why?
Rural Health
1
2017
102
0.150
 Why?
Diagnosis, Differential
1
2020
1136
0.150
 Why?
Odds Ratio
1
2018
604
0.140
 Why?
Mammography
1
2016
95
0.140
 Why?
Internship and Residency
1
2022
501
0.140
 Why?
Rural Health Services
1
2018
175
0.140
 Why?
Cytodiagnosis
2
2013
44
0.130
 Why?
Genetic Predisposition to Disease
1
2018
570
0.130
 Why?
Case-Control Studies
1
2018
1228
0.130
 Why?
National Cancer Institute (U.S.)
1
2015
35
0.130
 Why?
Cross-Sectional Studies
3
2021
1693
0.130
 Why?
Prospective Studies
9
2017
2604
0.130
 Why?
Risk Assessment
2
2018
1361
0.130
 Why?
Survival Rate
1
2017
951
0.130
 Why?
Uterine Cervical Neoplasms
1
2017
276
0.120
 Why?
Young Adult
4
2018
4318
0.120
 Why?
Algorithms
1
2018
697
0.120
 Why?
Needs Assessment
1
2015
154
0.120
 Why?
Career Mobility
2
2021
26
0.120
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
39
0.110
 Why?
Patient Care Planning
1
2013
79
0.110
 Why?
Monitoring, Intraoperative
3
2014
66
0.110
 Why?
Sigmoidoscopy
1
2012
10
0.110
 Why?
Reagent Kits, Diagnostic
1
2012
22
0.110
 Why?
Health Services
1
2012
81
0.100
 Why?
Colonoscopy
1
2012
105
0.100
 Why?
Lymph Node Excision
4
2008
140
0.100
 Why?
Feces
1
2012
135
0.100
 Why?
Receptors, Estrogen
2
2015
131
0.100
 Why?
Reproducibility of Results
1
2015
1304
0.100
 Why?
Lymphedema
2
2008
43
0.100
 Why?
Fructose
1
2010
29
0.100
 Why?
Treatment Outcome
9
2017
5604
0.090
 Why?
Registries
1
2013
553
0.090
 Why?
Pancreatic Neoplasms
1
2013
234
0.090
 Why?
Carbon
1
2010
61
0.090
 Why?
Patient Compliance
1
2012
249
0.090
 Why?
Clinical Competence
1
2013
446
0.090
 Why?
History, 21st Century
1
2010
62
0.090
 Why?
Risk Factors
3
2024
3935
0.090
 Why?
Carcinoma in Situ
2
2006
74
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1056
0.080
 Why?
Zambia
2
2018
2
0.080
 Why?
Patient Acceptance of Health Care
1
2012
333
0.080
 Why?
Delivery of Health Care
1
2011
327
0.080
 Why?
Prochlorperazine
1
2006
7
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
21
0.070
 Why?
Antiemetics
1
2006
35
0.070
 Why?
Education, Medical, Continuing
1
2006
80
0.070
 Why?
Receptor, erbB-2
1
2006
79
0.070
 Why?
Sensitivity and Specificity
3
2004
923
0.070
 Why?
Body Weights and Measures
1
2005
20
0.070
 Why?
Intraoperative Care
2
2003
57
0.070
 Why?
Gadolinium
1
2005
54
0.070
 Why?
Predictive Value of Tests
2
2013
1048
0.070
 Why?
Biopsy
2
2004
692
0.070
 Why?
Interprofessional Relations
1
2006
97
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Models, Theoretical
1
2006
184
0.060
 Why?
Neoadjuvant Therapy
2
2017
125
0.060
 Why?
Botulinum Toxins, Type A
1
2004
14
0.060
 Why?
Education, Medical
1
2006
107
0.060
 Why?
Imaging, Three-Dimensional
1
2005
171
0.060
 Why?
Anthracyclines
1
2024
25
0.060
 Why?
Cytological Techniques
1
2003
15
0.060
 Why?
Contrast Media
1
2005
221
0.060
 Why?
Pain, Postoperative
1
2004
161
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
45
0.060
 Why?
Neoplasm Grading
2
2014
131
0.060
 Why?
Preoperative Care
3
2014
184
0.060
 Why?
Humanism
1
2002
5
0.050
 Why?
Confidence Intervals
1
2002
167
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Program Development
1
2002
199
0.050
 Why?
Leadership
1
2021
114
0.050
 Why?
Vacuum
2
2011
14
0.040
 Why?
Neoplasm Invasiveness
2
2010
295
0.040
 Why?
Curriculum
1
2002
429
0.040
 Why?
Stereotaxic Techniques
2
2010
36
0.040
 Why?
Angiopoietin-2
1
2017
16
0.040
 Why?
Angiopoietin-1
1
2017
18
0.040
 Why?
Receptor, TIE-2
1
2017
18
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
33
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
51
0.040
 Why?
Gene Frequency
1
2017
120
0.040
 Why?
Injections, Intralesional
2
2008
38
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
93
0.040
 Why?
Guidelines as Topic
1
2016
125
0.030
 Why?
Adolescent
3
2013
6897
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
230
0.030
 Why?
Regression Analysis
1
2017
445
0.030
 Why?
Radionuclide Imaging
2
2007
130
0.030
 Why?
Neovascularization, Pathologic
1
2017
168
0.030
 Why?
Coloring Agents
2
2007
84
0.030
 Why?
Educational Status
1
2016
260
0.030
 Why?
Genotype
1
2017
599
0.030
 Why?
Taxoids
1
2015
45
0.030
 Why?
Receptors, Progesterone
1
2015
57
0.030
 Why?
Cyclophosphamide
1
2015
172
0.030
 Why?
Cohort Studies
2
2011
1543
0.030
 Why?
Touch
1
2013
27
0.030
 Why?
Ultrasonography, Doppler
1
2014
57
0.030
 Why?
Carcinoma
1
2015
153
0.030
 Why?
Angiogenesis Inhibitors
1
2015
203
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
240
0.030
 Why?
Disease-Free Survival
1
2014
485
0.030
 Why?
Kaplan-Meier Estimate
1
2014
514
0.030
 Why?
Cicatrix
1
2011
43
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
16
0.020
 Why?
Plant Lectins
1
2010
10
0.020
 Why?
Glycosylation
1
2010
112
0.020
 Why?
Substrate Specificity
1
2010
209
0.020
 Why?
Actins
1
2010
132
0.020
 Why?
Tumor Cells, Cultured
1
2010
477
0.020
 Why?
Cell Movement
1
2010
271
0.020
 Why?
Breast Neoplasms, Male
1
2009
6
0.020
 Why?
Pilot Projects
1
2011
808
0.020
 Why?
Arm
1
2008
52
0.020
 Why?
Phenotype
1
2010
820
0.020
 Why?
Cost-Benefit Analysis
1
2008
291
0.020
 Why?
Administration, Rectal
1
2006
10
0.020
 Why?
Positron-Emission Tomography
1
2008
322
0.020
 Why?
Primary Prevention
1
2006
47
0.020
 Why?
Probability
1
2006
176
0.020
 Why?
Cell Line, Tumor
1
2010
1550
0.020
 Why?
Drug Administration Schedule
1
2006
401
0.020
 Why?
Carcinoma, Ductal
1
2004
8
0.020
 Why?
Tissue Expansion
1
2004
4
0.020
 Why?
Administration, Oral
1
2006
459
0.020
 Why?
Pectoralis Muscles
1
2004
9
0.020
 Why?
Spasm
1
2004
8
0.020
 Why?
Rectus Abdominis
1
2004
9
0.020
 Why?
Laser Coagulation
1
2004
27
0.020
 Why?
Cryosurgery
1
2004
38
0.020
 Why?
Sampling Studies
1
2004
40
0.020
 Why?
Multivariate Analysis
1
2006
643
0.020
 Why?
Statistics, Nonparametric
1
2004
232
0.020
 Why?
Injections
1
2003
61
0.010
 Why?
Chi-Square Distribution
1
2004
318
0.010
 Why?
Pain Measurement
1
2004
246
0.010
 Why?
Ultrasonography
1
2004
480
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1476
0.010
 Why?
Length of Stay
1
2004
683
0.010
 Why?
Analgesics, Opioid
1
2004
501
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (24) people
_
Same Department Expand Description
Search Department